Nabla vs Suki (2026)
Two answers to what the microphone is for. Nabla documents, with an ambient scribe, dictation and E/M coding suggestions, integrations with Epic, athenahealth, Oracle Health, NextGen, Greenway and Arya, an independent randomized trial and a published price. Suki operates the chart, adding voice commands to ambient capture and dictation that order medications, navigate, query the patient record and stage orders for review, with bidirectional integrations across Epic, Oracle Health, athenahealth, MEDITECH and Elation, and Suki Platform for vendors that want to embed it. The two integration lists overlap on Epic, Oracle Health and athenahealth and diverge after that. If your failure mode is the note itself, across NextGen, Greenway or Arya sites or with trial evidence behind the purchase, start with Nabla. If it is the clicks around the visit, start with Suki.
- Nabla integrates with NextGen, Greenway and Arya alongside Epic, athenahealth and Oracle Health, the three systems both vendors name.
- Nabla cut time in notes by 9.5 percent against usual care in a UCLA Health randomized trial published in NEJM AI, the only arm to meet the primary endpoint.
- The price and data lifecycle are public: $119 a month per clinician after a 30 day trial, audio not stored by default, a 14 day retention window and no training on customer data.
- Voice commands control the EHR, ordering medications, navigating charts, querying the specific patient record, staging orders for review and pulling schedules.
- Suki adds MEDITECH and Elation to the three shared systems, with bidirectional integrations throughout and a partner program reaching MEDENT, Azalea Health and WellSky.
- Coding and chart questions are built in, with ICD-10, E/M and HCC coding assistance, pre visit summaries and clinical questions answered against the patient record, and audio and transcripts deleted after 30 days by default.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Nabla and Suki are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Nabla
-
Product / capability
Nabla released version 2026-08-25 of its Core API.
Source -
Pricing / packaging
Nabla appears to have withdrawn public per month pricing in favor of a demo and contract sales motion, particularly for organizations.
Source
Suki
-
Product / capability
Suki launched Suki Dictation, a standalone clinical dictation product built natively inside Epic and Meditech rather than delivered as a separate application alongside them.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Nabla sells an ambient AI assistant that listens to the visit and drafts a structured clinical note, together with dictation and E/M coding suggestions, to health systems, medical groups and individual clinicians. The company reports more than 85,000 clinicians across more than 130 health organizations and more than 20 million patient encounters a year.
Source: AI Health Index, July 2026
Suki pairs ambient documentation with a voice command layer over the EHR. Clinicians can dictate, capture visits ambiently, or use voice commands to order medications, navigate charts, query patient records, stage orders for review and pull schedules. The product also offers ICD-10, E/M and HCC coding assistance, chart aware clinical questions answered against the patient record, and pre visit summaries.
Source: AI Health Index, July 2026
Questions buyers ask
How do Nabla and Suki work with the EHR?
Nabla pulls patient history and visit context from the EHR, exports structured notes into EHR templates, and places vital signs, diagnoses and patient instructions into charts, flowsheets and clinical fields. The systems named are Epic, athenahealth, Oracle Health, NextGen, Greenway and Arya.
A clinician speaks the recommended orders, and Suki structures, codes and stages them in the EHR for review and sign off. At launch, Suki named labs, imaging, referrals and other order types across Epic, Cerner and MEDITECH as the next step. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
How do Nabla and Suki handle patient data?
Audio is not stored by default, notes are kept for 14 days from the moment an encounter is created, and a customer can shorten that window, down to a few hours according to Nabla's French compliance page. On expiry the data leaves the application and remains only in backups, which expire seven days later.
Suki does not identify the clinician or the patient in voice recordings, creates and keeps no voice signatures, and uses voice only to transcribe and summarize the note. Audio and transcripts are permanently deleted after 30 days, and the final clinical note is kept for the length of the service contract. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
Which settings and specialties do Nabla and Suki cover?
With Nabla, customers range from individual practices to large health systems, and emergency and inpatient clinicians can document on mobile inside Epic. Nabla supports more than 35 languages, from English, Spanish and French to several Arabic dialects, Hindi, Mandarin and Haitian Creole.
In Suki's case, the homepage claims use across more than 100 specialties, on desktop and on iOS and Android devices, in various care settings. Integration with Epic, Oracle Health, athenahealth and MEDITECH puts the product inside the EHRs most US health systems run, from large integrated networks down to ambulatory practices. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
What evidence is published for Nabla and Suki?
In Lukac and colleagues, NEJM AI, published 26 November 2025 (NCT06792890), 238 outpatient physicians across 14 specialties at UCLA Health were randomized in equal thirds to Nabla, Microsoft DAX Copilot or usual care for two months. Nabla cut time in notes by 9.5 percent against control and was the only arm to meet the primary endpoint; the DAX arm reached 1.7 percent and was not statistically significant.
With Suki, deployment scale carries most of the public case. MedStar Health expanded its partnership and put the product in front of thousands of clinicians across ambulatory specialties, alongside partnerships with Zoom and athenahealth. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Volume figures for both vendors are vendor published. Suki stages orders for clinician review rather than submitting them, but publishes no accuracy figure for command interpretation, and a misread medication order carries more consequence than a flawed sentence. An earlier version of this comparison said Nabla uses session data to train its models by default, that its free tier lacks a business associate agreement, and that Suki does not address model training in its published materials.
Nabla's terms and compliance page say otherwise, and Suki states that anything it uses for model training is de identified. All three statements were corrected on 10 October 2026. Suki publishes no price.